Arcadia Biosciences (RKDA)
(Delayed Data from NSDQ)
$2.68 USD
-0.25 (-8.53%)
Updated Aug 2, 2024 03:49 PM ET
After-Market: $2.77 +0.09 (3.36%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/13/24 |
---|---|
Current Quarter | 1.27 |
EPS Last Quarter | -1.78 |
Last EPS Surprise | 29.37% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.29 |
Next Year | -0.43 |
EPS (TTM) | -8.73 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.95M | 1.10M | 4.62M | 6.28M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.95M | 1.10M | 4.62M | 6.28M |
Low Estimate | 0.95M | 1.10M | 4.62M | 6.28M |
Year ago Sales | 1.39M | 1.60M | 5.66M | 4.62M |
Year over Year Growth Est. | -31.65% | -31.25% | -18.45% | 35.93% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.27 | -1.03 | -2.29 | -0.43 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | 1.27 | -1.03 | -2.29 | -0.43 |
High Estimate | 1.27 | -1.03 | -2.29 | -0.43 |
Low Estimate | 1.27 | -1.03 | -2.29 | -0.43 |
Year ago EPS | -2.64 | -1.83 | -11.02 | -2.29 |
Year over Year Growth Est. | 148.11% | 43.72% | 79.22% | 81.22% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.27 | -1.03 | -2.29 | -0.43 |
7 Days Ago | 1.27 | -1.03 | -2.29 | -0.43 |
30 Days Ago | 1.27 | -1.03 | -2.29 | -0.43 |
60 Days Ago | 1.27 | -1.03 | -2.29 | -0.43 |
90 Days Ago | -1.47 | -1.00 | -5.01 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.27 | -1.03 | -2.29 | -0.43 |
Zacks Consensus Estimate | 1.27 | -1.03 | -2.29 | -0.43 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.78 | -2.48 | -1.83 | -2.64 | NA |
Estimate | -2.52 | -2.68 | -2.67 | -4.92 | NA |
Difference | 0.74 | 0.20 | 0.84 | 2.28 | 1.02 |
Surprise | 29.37% | 7.46% | 31.46% | 46.34% | 28.66% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more